Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
A Agilent Technologies, Inc. daily Stock Chart
A [NYSE]
Agilent Technologies, Inc.
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
IndexS&P 500 P/E24.50 EPS (ttm)2.56 Insider Own0.10% Shs Outstand318.77M Perf Week-2.93%
Market Cap19.96B Forward P/E21.18 EPS next Y2.96 Insider Trans-5.98% Shs Float316.75M Perf Month-2.89%
Income831.00M PEG2.26 EPS next Q0.74 Inst Own87.60% Short Float1.64% Perf Quarter-3.57%
Sales4.81B P/S4.15 EPS this Y49.40% Inst Trans0.34% Short Ratio2.13 Perf Half Y-3.44%
Book/sh14.26 P/B4.39 EPS next Y8.84% ROA3.50% Target Price79.08 Perf Year-8.98%
Cash/sh6.69 P/C9.37 EPS next 5Y10.84% ROE6.40% 52W Range60.42 - 75.00 Perf YTD-6.51%
Dividend0.60 P/FCF32.35 EPS past 5Y-8.50% ROI10.60% 52W High-16.52% Beta1.37
Dividend %0.96% Quick Ratio3.00 Sales past 5Y-8.20% Gross Margin54.80% 52W Low3.62% ATR1.82
Employees14500 Current Ratio3.60 Sales Q/Q8.00% Oper. Margin19.30% RSI (14)38.57 Volatility2.94% 2.68%
OptionableYes Debt/Eq0.39 EPS Q/Q35.70% Profit Margin6.20% Rel Volume1.40 Prev Close64.99
ShortableYes LT Debt/Eq0.39 EarningsNov 19 AMC Payout60.20% Avg Volume2.43M Price62.61
Recom1.80 SMA20-3.11% SMA50-6.79% SMA200-5.73% Volume3,392,057 Change-3.66%
Nov-12-18Downgrade Cleveland Research Buy → Neutral
Apr-09-18Upgrade Goldman Neutral → Buy
Nov-21-17Reiterated Barclays Overweight $67 → $71
Sep-26-17Resumed Goldman Neutral $68
Jul-13-17Upgrade Wells Fargo Market Perform → Outperform
Mar-15-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-18-17Initiated Deutsche Bank Buy $54
Jan-04-17Upgrade Barclays Equal Weight → Overweight $48 → $51
Nov-10-16Resumed Leerink Partners Outperform
May-17-16Reiterated Jefferies Buy $46 → $51
May-17-16Reiterated Barclays Equal Weight $42 → $45
Jan-07-16Reiterated Barclays Equal Weight $41 → $44
Jan-07-16Initiated Deutsche Bank Hold $42
Dec-09-15Upgrade Robert W. Baird Neutral → Outperform $45 → $48
Dec-08-15Upgrade Goldman Neutral → Buy
Nov-17-15Reiterated Barclays Equal Weight $44 → $41
Mar-10-15Initiated UBS Neutral $45
Nov-04-14Downgrade Robert W. Baird Outperform → Neutral $59 → $42
Jan-10-14Reiterated UBS Buy $57 → $65
Oct-01-13Downgrade Stifel Buy → Hold
Nov-19-18 11:51PM  Edited Transcript of A earnings conference call or presentation 19-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
09:59PM  Agilent Technologies Inc (A) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:48PM  Agilent Technologies Earnings, Revenue beat in Q4 Investing.com
05:40PM  Agilent Technologies (A) Q4 Earnings and Revenues Top Estimates Zacks
05:38PM  Agilent: Fiscal 4Q Earnings Snapshot Associated Press
05:00PM  Agilent Stock Surges on Q4 Earnings Beat InvestorPlace
04:05PM  Agilent Technologies Reports Fourth-Quarter Fiscal Year 2018 Financial Results Business Wire
04:03PM  Is Agilent Technologies Inc. (NYSE:A) A Good Stock To Buy? Insider Monkey
09:53AM  Agilent (A) Hikes Quarterly Dividend, Rewards Shareholders Zacks
Nov-16-18 11:00AM  Agilent Expands Cell Analysis R&D Capabilities in Ireland Business Wire
Nov-15-18 07:59AM  Will New Technologies Benefit Agilent (A) in Q4 Earnings? Zacks
Nov-14-18 05:30PM  Agilent Completes Acquisition of ACEA Biosciences Business Wire
04:05PM  Agilent Technologies Increases Cash Dividend to 16.4 Cents per Share Business Wire
Nov-12-18 01:00PM  Agilent Technologies to Present at Evercore ISI HealthCONx Business Wire
10:30AM  Agilent Technologies (A) Earnings Expected to Grow: Should You Buy? Zacks
Nov-10-18 09:54AM  Biotech stocks have been hit hard here are ones analysts like best for a rebound MarketWatch
Nov-06-18 10:12PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Align Technology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Nov-05-18 02:07PM  Twist Bioscience IPO: What Investors Need to Know Motley Fool
Nov-02-18 01:55PM  Agilent Introduces New ICP-MS Water Analyzer Solution Business Wire
Nov-01-18 11:00AM  Agilent Introduces Groundbreaking UV-Vis Spectrophotometer for Pharmaceutical, Biomedical, and Academic Laboratories Business Wire
Oct-31-18 11:00AM  Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution Business Wire
09:00AM  Analysis: Positioning to Benefit within At Home Group, Synopsys, Agilent Technologies, AGNC Investment, Helios and Matheson Analytics, and Tech Data Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-29-18 12:39PM  Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Biosciences S-1 Registration Statement Business Wire
Oct-26-18 04:05PM  Agilent Welcomes New Senior Vice President of Corporate Development Business Wire
Oct-25-18 04:22PM  Passionate and Dedicated Employees Earn Agilent Recognition by Forbes as a Worlds Best Employer Business Wire
Oct-24-18 06:02PM  West Sacramento Bayer CoLaborator fills up with New Zealand company American City Business Journals
02:00PM  Agilent Technologies to Host Webcast of Fourth-Quarter Fiscal Year 2018 Financial Results Conference Call Business Wire
02:00PM  8 Overlooked Stocks Poised For Big Contrarian Gains Investopedia
Oct-19-18 01:32PM  When Should You Buy Agilent Technologies Inc (NYSE:A)? Simply Wall St.
10:42AM  Can Automotive Strength & Acquisitions Aid AVX Q2 Earnings? Zacks
Oct-12-18 07:15AM  Agilent Technologies Enters Oversold Territory Zacks
Oct-08-18 09:30AM  TER vs. A: Which Stock Is the Better Value Option? Zacks
08:00AM  Report: Exploring Fundamental Drivers Behind Ebix, Southwest Gas, Campbell Soup, La-Z-Boy, At Home Group, and Agilent Technologies New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-04-18 09:35AM  Staring down IP theft lawsuit, synthetic biology company seeks $86M IPO American City Business Journals
Oct-01-18 11:00AM  Agilent Brings Greater Clarity and Speed to Chemical Imaging Business Wire
Sep-26-18 03:43PM  Agilent Technologies, Inc. -- Moody's affirms Agilent's Baa2 senior unsecured ratings Moody's
09:17AM  Agilent Eyes Cell Analysis Portfolio Expansion, To Buy ACEA Zacks
06:00AM  ACEA Biosciences to be Acquired by Agilent Technologies Business Wire
Sep-25-18 09:00PM  Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences Business Wire
Sep-21-18 11:49PM  Factbox - U.S. companies react on impact of Trump trade tariffs Reuters
06:10PM  Factbox - U.S. companies react on impact of Trump trade tariffs Reuters
09:30AM  TER vs. A: Which Stock Should Value Investors Buy Now? Zacks
Sep-19-18 04:15PM  Agilent Technologies Announces Cash Dividend of 14.9 Cents per Share Business Wire
Sep-18-18 06:40PM  Electronics Testing Equipment Outlook: Solid Demand Ahead Zacks
12:00PM  Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents Business Wire
Sep-17-18 01:52PM  A Life Science Tools And Diagnostics Pair Trade: Goldman Recommends Buying Agilent, Moving to Sidelines On Thermo Fisher Benzinga
11:43AM  Thermo Fisher shares fall as Goldman downgrades to neutral; Agilent added to conviction list MarketWatch
Sep-13-18 12:58PM  Who Are The Major Shareholders In Agilent Technologies Inc (NYSE:A)? Simply Wall St.
12:22PM  Why Is Agilent (A) Up 4.9% Since Last Earnings Report? Zacks
07:56AM  Health Care Heroes award winner: Dr. Allison Freeman, Allegheny Health Network American City Business Journals
Sep-10-18 08:20AM  Factbox: U.S. tech firms bemoan impact of Trump trade tariffs Reuters
Sep-07-18 11:00AM  Agilent Early Career Professor Award Presented to Christoph Thaiss at University of Pennsylvania Business Wire
Sep-06-18 11:00AM  Agilent Recognized as Aon Best Employer in Malaysia for 2018 Business Wire
09:30AM  TER vs. A: Which Stock Should Value Investors Buy Now? Zacks
Aug-23-18 08:56AM  5 Tech Stocks Momentum Investors Should Buy Right Now Zacks
08:04AM  Meet Group adds new one-on-one video chat feature, ups revenue American City Business Journals
Aug-21-18 11:00AM  Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma Business Wire
Aug-20-18 05:45PM  Edited Transcript of A earnings conference call or presentation 14-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
11:00AM  Agilent Receives 2018 IBO Industrial Design Gold Award for the Ultivo Triple Quadrupole LC/MS System Business Wire
Aug-17-18 04:30PM  Agilent Completes Acquisition of Young In Scientific Co. Ltd. Assets Business Wire
Aug-15-18 07:43AM  Stocks making the biggest moves premarket: M, STZ, EGN, GSK, WMT & more CNBC
Aug-14-18 09:26PM  Agilent Technologies Earnings Beat, Revenue Inline In Q3 Investing.com
08:22PM  Agilent Technologies, Inc. (A) Q3 2018 Earnings Conference Call Transcript Motley Fool
05:20PM  Agilent Technologies (A) Q3 Earnings and Revenues Surpass Estimates Zacks
05:01PM  Stocks making the biggest moves after hours: EGN, TEVA & more CNBC
04:18PM  Agilent: Fiscal 3Q Earnings Snapshot Associated Press
04:05PM  Agilent Technologies Reports Third-Quarter Fiscal Year 2018 Financial Results Business Wire
02:44PM  One of Humana's major shareholders slashed its position by 70 percent American City Business Journals
12:43PM  Should You Be Happy With Agilent Technologies Incs (NYSE:A) Performance Lately? Simply Wall St.
10:06AM  5 Top-Ranked S&P 500 Stocks to Buy on Market Dip Zacks
07:27AM  Agilent Technologies Q3 Earnings Preview Benzinga
05:44AM  Stocks rise as Turkish lira rebounds CNBC
05:40AM  Tesla and Musk, Cigna and Icahn, Home Depot, McDonald's - 5 Things You Must Know TheStreet.com
Aug-13-18 09:15AM  Turkey Ruins Week for Dow, S&P Zacks
Aug-10-18 05:07PM  Dan Loeb's Third Point trims Facebook stake but buys more Microsoft shares MarketWatch
Aug-09-18 03:21PM  San Antonio oil and gas explorer invests in downtown Houston office American City Business Journals
07:05AM  Will New Technologies Benefit Agilent (A) in Q3 Earnings? Zacks
Aug-08-18 11:15AM  6 Tech Stocks Poised to Smash Estimates This Earnings Season InvestorPlace
11:00AM  Agilent First to Release Software Supporting Standardized Data Format for Pharmaceutical Industry Business Wire
09:50AM  6 Tech Stocks Poised to Smash Estimates This Earnings Season Zacks
03:00AM  Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma Business Wire
Aug-06-18 11:16AM  Factors Setting the Tone for Shutterfly's (SFLY) Q2 Earnings Zacks
10:07AM  What's in Store for Booking Holdings (BKNG) in Q2 Earnings? Zacks
Aug-01-18 04:05PM  Agilent Technologies Completes Acquisition of ProZyme Business Wire
11:07AM  Overstock (OSTK) to Report Q2 Earnings: What's in Store? Zacks
Jul-31-18 05:42PM  Hologic shares rise after company tops quarterly expectations; CFO departs for Agilent MarketWatch
04:02PM  Hologic Announces Chief Financial Officer Change PR Newswire
04:02PM  Agilent Announces CFO Transition Business Wire
07:00AM  Free Technical Research on Agilent Technologies and Three More Medical Research Equities ACCESSWIRE
Jul-30-18 10:23AM  TripAdvisor (TRIP) to Report Q2 Earnings: What's in Store? Zacks
08:01AM  Will New Products, Expansion Aid GoDaddy (GDDY) Q2 Earnings? Zacks
07:59AM  Will Innovative Products Aid Fitbit's (FIT) Q2 Earnings? Zacks
Jul-27-18 10:52AM  Square (SQ) to Report Q2 Earnings: What's in the Cards? Zacks
07:55AM  Recent Analysis Shows Kala Pharmaceuticals, Integer, Carnival, Coty, Sykes Enterprises, and Agilent Technologies Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
07:52AM  Can Growing Partnerships Drive Baidu's (BIDU) Q2 Earnings? Zacks
07:51AM  MobileIron (MOBL) to Report Q2 Earnings: What's in Store? Zacks
07:50AM  Will Amkor (AMKR) Q2 Earnings Gain From Strong Auto Demand? Zacks
Jul-25-18 10:48AM  Fortive (FTV) to Report Q2 Earnings: What's in the Cards? Zacks
10:19AM  Mettler-Toledo (MTD) Q2 Earnings: Disappointment in Store? Zacks
Jul-24-18 08:00AM  Agilent Technologies to Host Webcast of Third-Quarter Fiscal Year 2018 Financial Results Conference Call Business Wire
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CLARK PAUL NDirectorSep 13Sale68.602,876197,29488,451Sep 14 03:02 PM
FIELDS HEIDIDirectorSep 11Option Exercise13.895,48276,14558,284Sep 13 09:44 AM
FIELDS HEIDIDirectorSep 11Sale67.735,482371,29652,802Sep 13 09:44 AM
KOH BOON HWEEDirectorJun 12Option Exercise13.8915,482215,04590,574Jun 13 05:48 PM
KOH BOON HWEEDirectorJun 12Sale66.386,931460,09983,643Jun 13 05:48 PM
FIELDS HEIDIDirectorJun 11Option Exercise13.895,00069,45057,682Jun 13 05:50 PM
FIELDS HEIDIDirectorJun 11Sale66.485,000332,37552,682Jun 13 05:50 PM
Kaltenbach PatrickSr Vice PresidentMar 29Option Exercise41.264,000165,04072,547Mar 29 06:29 PM
Kaltenbach PatrickSr Vice PresidentMar 29Sale67.284,000269,11368,547Mar 29 06:29 PM
FIELDS HEIDIDirectorMar 27Option Exercise13.895,00069,45057,563Mar 28 02:41 PM
FIELDS HEIDIDirectorMar 27Sale68.095,000340,45052,563Mar 28 02:41 PM
Gonsalves RodneyV.P., Corporate ControllerMar 13Option Exercise39.126,825266,99431,250Mar 14 04:40 PM
Gonsalves RodneyV.P., Corporate ControllerMar 13Sale71.236,825486,14524,425Mar 14 04:40 PM
Doak MarkSr. Vice PresidentMar 13Sale71.002,441173,31165,533Mar 14 04:37 PM
Kaltenbach PatrickSr Vice PresidentMar 12Option Exercise41.264,875201,14375,422Mar 14 09:36 AM
Kaltenbach PatrickSr Vice PresidentMar 12Sale71.386,875490,73868,547Mar 14 09:36 AM
HERBOLD ROBERT JDirectorFeb 05Option Exercise13.8915,482215,04575,937Feb 06 04:30 PM
McMullen Michael R.CEO and PresidentJan 29Option Exercise27.1921,850594,102324,687Jan 30 03:40 PM
McMullen Michael R.CEO and PresidentJan 29Sale75.0021,8501,638,750302,837Jan 30 03:40 PM
McMullen Michael R.CEO and PresidentJan 18Option Exercise27.1921,850594,102324,687Jan 19 01:54 PM
McMullen Michael R.CEO and PresidentJan 18Sale72.5021,8501,584,125302,837Jan 19 01:54 PM
McMullen Michael R.CEO and PresidentJan 05Option Exercise27.1943,7031,188,285346,540Jan 08 02:07 PM
McMullen Michael R.CEO and PresidentJan 05Sale70.0043,7033,059,210302,837Jan 08 02:07 PM
Doak MarkSr. Vice PresidentDec 18Option Exercise40.4615,567629,84880,379Dec 19 01:38 PM
Doak MarkSr. Vice PresidentDec 18Sale68.0015,5671,058,55667,958Dec 19 01:38 PM
Doak MarkSr. Vice PresidentDec 05Sale67.004,154278,31868,270Dec 06 05:02 PM
HIRSCH DIDIERSr. VP and CFONov 28Option Exercise26.1920,000523,800204,851Nov 29 06:22 PM
Kaltenbach PatrickSr Vice PresidentNov 28Option Exercise41.265,000206,30075,504Nov 29 06:25 PM
Thaysen JacobSr Vice PresidentNov 28Option Exercise41.2622,583931,77563,042Nov 29 06:30 PM
Thaysen JacobSr Vice PresidentNov 28Sale70.4122,5831,590,06940,459Nov 29 06:30 PM
Kaltenbach PatrickSr Vice PresidentNov 28Sale69.565,000347,80070,504Nov 29 06:25 PM
HIRSCH DIDIERSr. VP and CFONov 28Sale70.4020,0001,408,000184,851Nov 29 06:22 PM
HIRSCH DIDIERSr. VP and CFONov 27Option Exercise26.1920,000523,800204,851Nov 28 03:36 PM
HIRSCH DIDIERSr. VP and CFONov 27Sale69.4020,0001,388,000184,851Nov 28 03:36 PM
Kaltenbach PatrickSr Vice PresidentNov 22Option Exercise40.577,358298,54575,504Nov 27 02:49 PM
Kaltenbach PatrickSr Vice PresidentNov 22Sale69.287,358509,78570,504Nov 27 02:49 PM
HIRSCH DIDIERSr. VP and CFONov 22Sale69.0012,964894,516184,851Nov 27 02:48 PM
open in yahoo | open in reuters | open in google